Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Jerry B. Brown

33 indexed publications match this author name.

ORCID: 0000-0002-8139-2290
OpenAlex: https://openalex.org/A5043898578

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Clinical Trial 13 Depression 10 Safety 9 Animal Study 8 Pharmacology 7 Adverse Events 7 Receptor Pharmacology 7 Review Article 6 Anxiety 6 OCD 6 Drug Interactions 6 Observational Study 5

Journals

bioRxiv 3 The International Journal of Neuropsychopharmacology 2 Frontiers in pharmacology 2 Pharmaceuticals 1 ClinicalTrials.gov 1 medRxiv 1 Molecular psychiatry 1 Neuron 1

Publication history

A Randomized, Double-Blind, Placebo-Controlled Single-Ascending-Dose Study to Identify a Subperceptual Dose of Psilocybin in Healthy AdultsPharmaceuticals · 2026-09-21 Pilot Study on the Effects of Psilocybin on Belief Updating and Insight FormationClinicalTrials.gov · 2026-09-14 A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19 Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".Molecular psychiatry · 2025-12-01 Synaptic priming: A framework for pharmacotherapy in depression.Neuron · 2025-11-19 694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATINGThe international journal of neuropsychopharmacology · 2025-08-01 204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDERThe International Journal of Neuropsychopharmacology · 2025-07-31 551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHESThe International Journal of Neuropsychopharmacology · 2025-07-31 Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-07-01 ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01 A qualitative analysis of the psychedelic mushroom come-up and come-down.Npj mental health research · 2025-02-07 Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.Addiction (Abingdon, England) · 2025-01-30 Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behaviorNeuroscience Applied · 2025-01-01 Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin TreatmentbioRxiv · 2024-09-23 Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided ImageryClinical Endocrinology and Metabolism · 2024-08-30 Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-Grooming.bioRxiv: the preprint server for biology · 2024-06-29 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2024-03-01 The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-23 Perceptions of psychedelic-assisted therapy among Black Americans.Journal of mood and anxiety disorders · 2023-12-01 Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings.Psychedelic medicine (New Rochelle, N.Y.) · 2023-12-01 Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".Journal of affective disorders · 2023-10-01 Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05 Bedside to bench: the outlook for psychedelic research.Frontiers in pharmacology · 2023-01-01 Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International journal of molecular sciences · 2022-11-16 The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus · 2022-09-01 Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implicationsbioRxiv · 2022-07-23 Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTMbioRxiv · 2022-07-03 Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in pharmacology · 2021-01-01 Entheogens in Christian art: Wasson, Allegro, and the Psychedelic GospelsJournal of Psychedelic Studies · 2019-06-01 High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of psychopharmacology (Oxford, England) · 2018-07-01 Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical pharmacokinetics · 2017-12-01 Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in psychology · 2017-01-01 A rapid screening procedure for some "street drugs" by thin-layer chromatography.Journal of chromatography · 1971-12-30

Author directory